245 related articles for article (PubMed ID: 32503858)
1. Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis.
Moroni G; Gatto M; Tamborini F; Quaglini S; Radice F; Saccon F; Frontini G; Alberici F; Sacchi L; Binda V; Trezzi B; Vaglio A; Messa P; Sinico RA; Doria A
Ann Rheum Dis; 2020 Aug; 79(8):1077-1083. PubMed ID: 32503858
[TBL] [Abstract][Full Text] [Related]
2. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
Fanouriakis A; Kostopoulou M; Cheema K; Anders HJ; Aringer M; Bajema I; Boletis J; Frangou E; Houssiau FA; Hollis J; Karras A; Marchiori F; Marks SD; Moroni G; Mosca M; Parodis I; Praga M; Schneider M; Smolen JS; Tesar V; Trachana M; van Vollenhoven RF; Voskuyl AE; Teng YKO; van Leew B; Bertsias G; Jayne D; Boumpas DT
Ann Rheum Dis; 2020 Jun; 79(6):713-723. PubMed ID: 32220834
[TBL] [Abstract][Full Text] [Related]
3. Response to therapy at 6 months predicts long-term renal outcome in lupus nephritis with poor kidney function.
Luo H; Zhou Y; Chen G; Ren Q; Zhao J; Ye W; Qin Y; Li X
Lupus Sci Med; 2022 Dec; 9(1):. PubMed ID: 36581380
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease: the missing concept in the 2019 EULAR/ERA-EDTA recommendations for lupus nephritis.
Rojas-Rivera JE; Bakkaloglu SA; Bolignano D; Nistor I; Sarafidis PA; Stoumpos S; Cozzolino MG; Ortiz A
Nephrol Dial Transplant; 2023 Dec; 39(1):151-158. PubMed ID: 37433583
[TBL] [Abstract][Full Text] [Related]
5. Long-term renal outcomes in multi-ethnic Southeast Asians with lupus nephritis: a retrospective cohort study.
Lim CC; Tan HZ; Hao Y; Chin YM; Woo KT; Chan CM; Choo JCJ
Intern Med J; 2018 Sep; 48(9):1117-1123. PubMed ID: 29740923
[TBL] [Abstract][Full Text] [Related]
6. Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations.
Kostopoulou M; Fanouriakis A; Cheema K; Boletis J; Bertsias G; Jayne D; Boumpas DT
RMD Open; 2020 Jul; 6(2):. PubMed ID: 32699043
[TBL] [Abstract][Full Text] [Related]
7. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.
Bertsias GK; Tektonidou M; Amoura Z; Aringer M; Bajema I; Berden JH; Boletis J; Cervera R; Dörner T; Doria A; Ferrario F; Floege J; Houssiau FA; Ioannidis JP; Isenberg DA; Kallenberg CG; Lightstone L; Marks SD; Martini A; Moroni G; Neumann I; Praga M; Schneider M; Starra A; Tesar V; Vasconcelos C; van Vollenhoven RF; Zakharova H; Haubitz M; Gordon C; Jayne D; Boumpas DT;
Ann Rheum Dis; 2012 Nov; 71(11):1771-82. PubMed ID: 22851469
[TBL] [Abstract][Full Text] [Related]
8. Proteinuria and serum creatinine after 12 months of treatment for lupus nephritis as predictors of long-term renal outcome: a case-control study.
Braga FNHF; das Chagas Medeiros MM; Junior ABV; de Sousa Lima ME; Barros LCM; Pontes MX; de Sousa Lima AW; Fernandes PFCBC
Adv Rheumatol; 2022 Jan; 62(1):2. PubMed ID: 34983697
[TBL] [Abstract][Full Text] [Related]
9. Morphological Indexes: Can They Predict Lupus Nephritis Outcomes? A Retrospective Study.
Navarro D; Ferreira AC; Viana H; Carvalho F; Nolasco F
Acta Med Port; 2019 Oct; 32(10):635-640. PubMed ID: 31625875
[TBL] [Abstract][Full Text] [Related]
10. Risk factors to predict the development of chronic kidney disease in patients with lupus nephritis.
Park DJ; Kang JH; Lee JW; Lee KE; Kim TJ; Park YW; Lee JS; Choi YD; Lee SS
Lupus; 2017 Oct; 26(11):1139-1148. PubMed ID: 28420060
[TBL] [Abstract][Full Text] [Related]
11. Performance of the 2019 EULAR/ACR systemic lupus erythematosus classification criteria in a cohort of patients with biopsy-confirmed lupus nephritis.
Wang H; Gao Y; Ma Y; Cai F; Huang X; Lan L; Ren P; Wang Y; Chen J; Han F
Lupus Sci Med; 2021 Feb; 8(1):. PubMed ID: 33558437
[TBL] [Abstract][Full Text] [Related]
12. Chronic kidney disease in patients with childhood-onset systemic lupus erythematosus.
Sakamoto AP; Silva CA; Islabão AG; Novak GV; Molinari B; Nogueira PK; Pereira RMR; Saad-Magalhães C; Clemente G; Piotto DP; Aikawa NE; Pitta AC; Trindade VC; Appenzeller S; Carvalho LM; Rabelo-Junior CN; Fonseca AR; Sztajnbok FR; Santos MC; Bica BE; Sena EG; Moraes AJ; Fraga MM; Robazzi TC; Spelling PF; Scheibel IM; Cavalcanti AS; Matos EN; Guimarães LJ; Santos FP; Mota LMH; Bonfá E; Terreri MT;
Pediatr Nephrol; 2023 Jun; 38(6):1843-1854. PubMed ID: 36409367
[TBL] [Abstract][Full Text] [Related]
13. Impact of stringent response in proteinuria on long-term renal outcomes in proliferative lupus nephritis.
Won J; Lee JS; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
Lupus; 2019 Oct; 28(11):1294-1301. PubMed ID: 31583978
[TBL] [Abstract][Full Text] [Related]
14. Combination immunosuppressant therapy and lupus nephritis outcome: a hospital-based study.
Chen YM; Hung WT; Liao YW; Hsu CY; Hsieh TY; Chen HH; Hsieh CW; Lin CT; Lai KL; Tang KT; Tseng CW; Huang WN; Chen YH
Lupus; 2019 Apr; 28(5):658-666. PubMed ID: 30971165
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of lupus and lupus nephritis at a tertiary care center in Lebanon.
Koubar SH; Kort J; Kawtharani S; Chaaya M; Makki M; Uthman I
Lupus; 2019 Nov; 28(13):1598-1603. PubMed ID: 31554458
[TBL] [Abstract][Full Text] [Related]
16. Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes.
Mackay M; Dall'Era M; Fishbein J; Kalunian K; Lesser M; Sanchez-Guerrero J; Levy DM; Silverman E; Petri M; Arriens C; Lewis EJ; Korbet SM; Conti F; Tesar V; Hruskova Z; Borba EF; Bonfa E; Chan TM; Rathi M; Gupta KL; Jha V; Hasni S; West MR; Solomons N; Houssiau FA; Romero-Diaz J; Mejia-Vilet J; Rovin BH
Arthritis Rheumatol; 2019 Mar; 71(3):411-419. PubMed ID: 30225865
[TBL] [Abstract][Full Text] [Related]
17. Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis.
Parodis I; Ding H; Zickert A; Arnaud L; Larsson A; Svenungsson E; Mohan C; Gunnarsson I
Scand J Rheumatol; 2017 Jul; 46(4):263-272. PubMed ID: 27973968
[TBL] [Abstract][Full Text] [Related]
18. Wire-loop lesion is associated with serological immune abnormality, but not renal prognosis, in lupus nephritis.
Zoshima T; Hara S; Mizushima I; Nishioka R; Ito K; Fujii H; Yamada K; Nomura H; Kawano M
Lupus; 2020 Apr; 29(4):407-412. PubMed ID: 32041502
[TBL] [Abstract][Full Text] [Related]
19. Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort.
Gatto M; Saccon F; Andreoli L; Bartoloni E; Benvenuti F; Bortoluzzi A; Bozzolo E; Brunetta E; Canti V; Cardinaletti P; Ceccarelli F; Ciccia F; Conti F; De Marchi G; de Paulis A; De Vita S; Emmi G; Faggioli P; Fasano S; Fredi M; Gabrielli A; Gasparotto M; Gerli R; Gerosa M; Govoni M; Gremese E; Laria A; Larosa M; Mosca M; Orsolini G; Pazzola G; Petricca L; Ramirez GA; Regola F; Rossi FW; Rossini M; Salvarani C; Scarpato S; Tani C; Tincani A; Ubiali T; Urban ML; Zen M; Doria A; Iaccarino L
J Autoimmun; 2021 Nov; 124():102729. PubMed ID: 34600347
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and risk factors for chronic kidney disease in Chinese patients with biopsy-proven lupus nephritis.
Sui M; Ye X; Ma J; Yu C; Zhao S; Liu X; Li L; Cao J; Jia X; Xie R
Intern Med J; 2015 Nov; 45(11):1167-72. PubMed ID: 26109241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
